What You Need to Know About Vaccines

How much do you know about vaccines?

Clinical Research Associates will be enrolling influenza and shingles vaccine studies this fall for all ages. Please take a moment to arm yourself with the medical advice surrounding vaccines and please call our office if you have any questions about the safety and effectiveness of vaccines.

Here are some good articles to read. Source: MPR (Monthly Prescribing Reference.)

Pneumonia Vaccine:

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has issued updated recommendations on the use of pneumococcal vaccines in adults ≥65 years of age. Read full article.

Influenza Vaccine (Flu):

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has issued updated recommendations regarding the use of seasonal influenza vaccines for the 2014–2015 influenza season.

The updated recommendations for children ages 6 months–8 years state that two doses of influenza vaccine, given ≥4 weeks apart, should be administered during their first season of vaccination or if previous vaccination history is unknown to optimize immune response. Only one dose is required for children ages 6 months–8 years who previously received ≥1 dose of a 2013–2014 influenza vaccine due to the unchanged strains in the 2014–2015 vaccines. Read full article.

Flu Vaccine for Seniors

According to a study published in the New England Journal of Medicine, a high-dose, trivalent, inactivated influenza vaccine (IIV3-HD) is associated with improved protection for seniors against laboratory-confirmed influenza infection compared with standard-dose trivalent, inactivated influenza vaccine (IIV3-SD)CDC. Read full article.

Childhood Vaccines Safe, Not Linked to Autism, Says New Study

Concerns about vaccine safety have led some parents to decline recommended vaccination of their children, leading to the resurgence of diseases. This study systematically reviewed the literature on the safety of routine vaccines recommended for children in the United States. Read about the findings here.

Meningococcal Vaccine Recommendations Updated

New recommendations are presented for meningococcal vaccination in a policy statement published online July 28 in Pediatrics. Read complete article.

Not Enough Clinicians Are Discussing the HPV Vaccine with Parents

Despite a slight increase in the number girls and boys ages 13–17 receiving a human papillomavirus (HPV) vaccine since 2012, approximately one third of parents of girls and over half of parents of boys reported that their child's clinician had failed to recommended the HPV vaccination during office visits. These results from the 2013 National Immunization Survey-Teen (NIS-Teen) were published in the CDC's Morbidity and Mortality Weekly Report (MMWR). Read full article.

Long-Term Study Shows Sustained Results in HPV Vaccine

A long-term follow-up study shows the sustained efficacy, immunogenicity, and safety of GlaxoSmithKline's human papillomavirus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than 9 years, and vaccine efficacy (VE) against incident infection was 100%. This is the longest follow-up report for a licensed HPV vaccine. Read full article.